Channels - Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer :: FRELIP Discovery

Similar Items: Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

Quick Look
IRF1 Inhibits the Proliferation and Metastasis of Colorectal Cancer by Suppressing the RAS-RAC1 Pathway [Retraction]
Quick Look
Nationwide Analysis of Sociodemographic Disparities in Health‐Related Quality of Life of Colon Cancer Survivors
Quick Look
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Quick Look
Association of the Affordable Care Act With Receipt of Guideline‐Concordant Adjuvant Chemotherapy for Colon and Non‐Small Cell Lung Cancer
Quick Look
Association Between ABO Blood Group and Survival in Early-Stage Colon Cancer: A Single-Center Retrospective Cohort Analysis
Quick Look
Added value of adjuvant chemotherapy in patients with node-positive pT1-2 colon cancer: a national SNAPSHOT analysis
Quick Look
Bone Marrow Failure Model Mimics Aplastic Anemia Patients: Single‐Cell Landscape of Immune Response Reveals Novel Mechanisms of Immune Imbalance in AA
Quick Look
Regulation, Function, and Expression of Matrix Metalloproteinase-9 in Colon, Lung, and Breast Cancers In Silico and Experimental Methods From Iraqi Metastatic Patients
Quick Look
Robust response to pembrolizumab in temozolomide-associated hypermutated and microsatellite instability-high functional pancreatic neuroendocrine tumor
Quick Look
A Prognostic Risk Model Based on Immune Genes in Thyroid Cancer and Its Correlation With Tumor‐Associated Immune Cell Infiltration Abundance
Quick Look
Toward multimodal integration of colorectal cancer and chronic kidney disease: transcriptomic modeling as a framework for the SIRIO study “Spatial radiomics and transcriptomics to the discovery of the cross-link between colon cancer and chronic kidney disease”
Quick Look
A Novel Prognostic Model Based on Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Cancer Patients Treated with Immune Checkpoint Inhibitors
Quick Look
High‐Intensity Interval Training Boosts Immune Cells in Advanced Cancer Patients and Healthy Controls: Implications for Cancer Care
Quick Look
A rare case of medullary carcinoma of colon: Clinical implications and role of adjuvant therapy
Quick Look
Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review
Quick Look
To screen or not to screen: complexity of SDHA mutation management
Quick Look
EGFR Mutations and Recurrence Outcomes in Resected Non‐Small Cell Lung Cancer: An Updated 2015–2025 Systematic Review and Meta‐Analysis
Quick Look
Development and Validation of a Predictive Nomogram for Diagnosing Colorectal Cancer Based on Immune‐Nutritional Score
Quick Look
Induced Electric Fields Inhibit Breast Cancer Growth and Metastasis and Modulate the Immune Tumor Microenvironment
Quick Look
Immune Cell Infiltration and Causal Relationships with Prostate Cancer: A Transcriptomic and Mendelian Randomization Study
Quick Look
An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
Quick Look
Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune‐Related Adverse Events in Patients With Bladder Cancer
Quick Look
Atractylodes Macrocephala Polysaccharides Regulate the Innate Immunity of Colorectal Cancer Cells by Modulating the TLR4 Signaling Pathway [Retraction]
Quick Look
Real‐World Survival Over 25 Years in Extensive‐Stage Small‐Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors